Ltd Zurich now owns 1,184,308,095 shares of the conglomerate’s stock valued at $284,233,943,000 after buying an additional 1,183,126,676 shares during the last quarter. Moneta Group Investment Advisors LLC raised its stake in Danaher by 96,490.5% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 23,287,013 shares of the conglomerate’s fp markets forex broker review stock worth $6,180,839,000 after buying an additional 23,262,904 shares during the period. Norges Bank acquired a new position in Danaher during the 4th quarter worth approximately $2,057,164,000. Generation Investment Management LLP purchased a new stake in shares of Danaher in the first quarter worth approximately $374,240,000.
- The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
- The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
- As of September 30th, there was short interest totaling 5,720,000 shares, a decrease of 9.4% from the September 15th total of 6,310,000 shares.
- With its current Zacks Industry Rank of 156, this industry ranks in the bottom 39% of all industries, numbering over 250.
Danaher announced a quarterly dividend on Tuesday, September 12th. Shareholders of record on Thursday, October 12th will be given a dividend of $0.27 per share on Friday, October 27th. Danaher faces potential risks and challenges, including market fluctuations, regulatory changes, and economic uncertainties. However, its proactive risk management strategies mitigate potential impacts on the company’s financial performance. Danaher Corporation boasts a leadership team comprising highly accomplished individuals with diverse expertise, driving the company’s success and strategic direction.
S&P 500, Nasdaq Brace For Cautious Open After Shutdown Crisis Drama As Traders Eye Powell’s Speech, Economic Data (UPDATED)
Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets. The scores are based on the trading styles of Value, Growth, and Momentum.
- To see all exchange delays and terms of use please see Barchart’s disclaimer.
- Danaher saw a decrease in short interest in the month of September.
- It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
- Rainer M. Blair holds the positions of President, Chief Executive Officer, and Director, leading Danaher’s day-to-day operations and spearheading its growth strategies.
- Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To exploit this, we’ve formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
Is It Time to Sell DHR? Shares are down today.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Thursday, October 12th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Wednesday, October 11th.
A comparison between the balance sheets of two industrial giants speaks volumes about the importance of a strong balance sheet. On a risk/reward basis, they aren’t a great value right now, but these are excellent stocks to watch for a better entry point on. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.
GE HealthCare Stock Has Had a Great Start. More Gains Lie Ahead.
The company was founded in 1969 and is headquartered in Washington, the District of Columbia. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.17% per year. These returns cover a period from January 1, 1988 through September 4, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.
There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. There’s life after COVID-19 for Danaher, and the stock has a long pathway of growth ahead of it. These exchange-traded funds track companies in this biotech space.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
News & Analysis
27 employees have rated Danaher Chief Executive Officer Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among the company’s employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $8.82 per share and a revenue of $28.49 billion, indicating changes of -19.45% and -9.47%, respectively, from the former year. In the latest market close, Danaher (DHR Quick QuoteDHR – Free Report) reached $209.43, with a -0.03% movement compared to the previous day. The stock’s change was more than the S&P 500’s daily loss of 0.5%. At the same time, the Dow added 0.12%, and the tech-heavy Nasdaq lost 1.23%.
Stifel Nicolaus decreased their price target on Danaher from $250.00 to $240.00 and set a “hold” rating for the company in a research report on Wednesday, July 26th. Raymond James lifted their price objective on Danaher from $270.00 to $290.00 and gave the company an “outperform” rating in a research note on Wednesday, July 26th. Wells Fargo & Company dropped their price objective on Danaher from $285.00 to $247.00 and set an “overweight” rating for the company xcritical review in a research note on Tuesday, October 3rd. Royal Bank of Canada lifted their price target on Danaher from $260.00 to $292.00 in a research note on Wednesday, July 26th. Finally, KeyCorp lowered their target price on Danaher from $325.00 to $300.00 and set an “overweight” rating for the company in a research note on Wednesday, September 27th. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock.
Get this delivered to your inbox, and more info about our products and services. Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. The Diversified Operations industry is part of the Conglomerates sector. With its current Zacks Industry Rank of 156, this industry ranks in the bottom 39% of all industries, numbering over 250.
Financial Calendars
Danaher is involved in designing, manufacturing, and marketing a broad array of products and services. Its offerings span medical diagnostics equipment, life sciences and diagnostics tools, environmental solutions, water quality analysis systems, industrial automation tools, and other specialized instruments. Danaher’s mission is to leverage its technological expertise and commitment to continuous improvement to develop innovative solutions that enhance human well-being and drive sustainable growth. Danaher’s mission is to innovate and provide high-quality solutions that positively impact people’s lives worldwide.
This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Investors should closely monitor any recent news or events that may have impacted Danaher’s share price, such Kraken Review as industry developments or major acquisitions. Its competitive advantages, including a broad product portfolio and emphasis on innovation, position it well within its industries.
The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. While Danaher currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys. Research indicates that these estimate revisions are directly correlated with near-term share price momentum.